Hackensack Meridian Health Southern Ocean Medical Center will once again host its annual Women’s Health Night on Wednesday, October 30, 2019. The free event will take place from 5:30 p.m. to 8:30 p.m. on the first floor of the hospital in Manahawkin.
Cases of the flu are already on the rise around the nation as flu season begins. Johns Hopkins Medicine experts say now is the time to fight against the flu as the number of people getting sick from the potentially life-threatening virus will increase in the coming months. Doctors recommend everyone 6 months and older get the flu vaccine each year to prevent the virus or reduce the seriousness if you do get sick.
The Unity Consortium is thrilled to welcome newest member, Ethan Lindenberger, a 19-year old American activist known for his opposition to vaccine misinformation efforts.
As the 2019–20 flu season gets underway, Johns Hopkins Medicine experts will be available throughout the season to talk with your newsroom about the epidemiology of this year’s virus, as well as provide important information about this year’s vaccine. Flu cases have already begun to appear in the U.S. Flu activity tends to increase in October and can run as late as May.
Infectious disease experts David Cennimo at Rutgers New Jersey Medical School and Tanaya Bhowmick at Rutgers Robert Wood Johnson Medical School discuss this year’s flu season, the effectiveness of the vaccine and how you can protect yourself.
The University of Georgia has signed a contract with the National Institutes of Health for an initial award of $8 million to develop a new, more advanced influenza vaccine designed to protect against multiple strains of influenza virus in a single dose. The total funding could be up to $130 million over seven years if all contract options are exercised.
As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases (NIAID), with an initial award of approximately $29.6 million in first-year funding.
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of research demonstrating that discrete choice experiments are able to predict real-world healthcare choices.
The National Institute of Allergy and Infectious Diseases research contract is one of the largest ever awarded to UMSOM and includes an initial award of approximately $2.5 million to conduct clinical testing of influenza vaccines. Total funding over seven years could be as much as $201 million if all options are exercised in the NIAID contract.
The UM School of Medicine's Contract awarded by the National Institute of Allergy and Infectious Diseases could fund up to $201 Million in influenza research over seven years.
Patrick Wilson, PhD, professor of medicine and rheumatology at the University of Chicago, and a group of researchers from three other institutions have received aGrand Challenge for Universal Influenza Vaccine Development grant – a $12 million initiative funded by the Bill & Melinda Gates Foundation and Flu Lab.
General probiotic use in the U.S. could save the health care payer and the economy around $1.4 billion in medical bills and lost productivity due to acute respiratory tract infections (RTIs), a new study found. The researchers developed an economic model to estimate the cost savings by simulating a population representative of the national demographics. The savings included the cost of averted antibiotic prescriptions, RTI episodes and sick days causing productivity loss.
For researchers with The Ohio State University College of Veterinary Medicine, the work to identify new flu strains and increase the effectiveness of the flu vaccine begins in an unlikely place – pig barns at state and county fairs nationwide.
Scientists can use cell cultures from the tissues of swine nasal passages, tracheas and lungs to study influenza viruses that infect swine and humans. The outcomes are closer to what's happening inside the animal.
Parents given a handout with flu facts at their pediatrician’s office were significantly more likely to get their kids vaccinated before the end of flu season, Columbia pediatricians have found.
An investigational flu drug cures mice infected with the rare but deadly Bourbon virus, according to a new study from Washington University School of Medicine in St. Louis. The findings potentially could lead to a treatment.
A universal flu vaccine that could prevent a potential influenza pandemic has been a holy grail for epidemiologists around the world ever since the first flu vaccines were developed in 1938.
Ron Trewyn, Kansas State University NBAF liaison, writes to encourage people to watch THE HOT ZONE, a National Geographic limited series inspired by two Kansas State University veterinarians and leaders and their work during the 1989 Ebola-related outbreak in Virginia.
Scientists from the University of Adelaide’s Research Centre for Infectious Diseases have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, the world’s most deadly respiratory diseases.
Research uncovers key mechanism that allows some of the deadliest human RNA viruses to orchestrate the precise copying of the individual pieces of their viral genome and replicate.
Research reveals that the tail end of a virus’s RNA plays a key role in ensuring each segment of the viral genome is copied in the correct amount.
Experiments show the viral replication machinery latches onto the 5' end of the virus’s RNA strand, a move that activates the enzyme to start copying at the opposite end of a specific segment.
The findings identify new targets to inhibit viral replication and may inform the development of a novel class of antiviral drugs.
A new technology developed by the University of Wisconsin–Madison’s Yoshihiro Kawaoka may make H3N2 vaccine development a bit easier. In Nature Microbiology today [April 29, 2019], Kawaoka and his team describe a new cell line that enables better growth of H3N2 for vaccine use. The virus is also far less likely to mutate during production using this cell line, improving the chances of a match between vaccine and circulating influenza viruses.
Folk medicines and herbal products have been used for millennia to combat a whole range of ailments, at times to the chagrin of modern scientists who have struggled to explain their medicinal benefits.
Research conducted in mice suggests the food additive tert-butylhydroquinone (tBHQ)—found in many common products from frozen meat to crackers and fried foods—suppresses the immune response the body mounts when fighting the flu.
Southern Research announced today that April M. Brys, Ph.D., an experienced life sciences executive with a strong track record in research and leadership roles, has been named vice president of the non-profit organization’s Drug Development division.
When flu season peaks after mid-winter, tens of thousands of influenza cases and hundreds of deaths can likely be avoided if older adults wait until October to get their flu immunization, a University of Pittsburgh School of Medicine analysis reveals.
An annual influenza season forecasting challenge issued by the US Centers for Disease Control provides unique insight into epidemic forecasting, according to a study published in the journal Scientific Reports.
Sharon Wright, MD, MPH, BIDMC’s Director of Infection Control/Hospital Epidemiology, shares everything you need to know about the flu – from how to prepare before you get sick and when to call a doctor.
The Centers for Disease Control reports that influenza activity in Alabama is now widespread and likely to increase. Alabama’s Department of Public Health also reports that almost every Alabama county is experiencing significant flu activity. As Alabama and the rest of the country enter the height of flu season, University of Alabama at Birmingham medical caregivers want to remind the public that, if you are normally a healthy person who is experiencing flu-like symptoms — high fever, muscle or body aches throughout the body, exhaustion, and loss of appetite — do not go to the emergency department.
Researchers from the National Institutes of Health have discovered that antibodies that may form the basis of a universal flu vaccine inhibit a second viral protein in addition to the one that they bind. The study, to be published January 25 in the Journal of Experimental Medicine, reveals that antibodies that recognize the viral surface protein hemagglutinin can also inhibit the viral neuraminidase, and that this enhances antibody neutralization of the virus and the activation of innate immune cells with anti-viral activity.
Arnold Monto, professor of epidemiology at the University of Michigan School of Public Health, has been studying the spread of the flu virus and the effectiveness of vaccines and antiviral medications for more than five decades.
Pregnant women with influenza are more likely to experience complications, but how this affects infants is unclear. A newBirth Defects Researchstudy uncovers the potential risks to infants.
Gaps in the logic of how we restock flu vaccines may be costing hundreds of lives, or more. A new model to tweak the gaps could save hundreds to hundreds of thousands of people and millions to multiple millions in medical costs.
ALBUQUERQUE, N.M. — When people are in the early stages of an undiagnosed disease, immediate tests that lead to treatment are the best first steps. But a blood draw — usually performed by a medical professional armed with an uncomfortably large needle — might not be quickest, least painful or most effective method, according to new research.